v3.26.1
INCOME TAXES (Details - Deferred tax assets) - USD ($)
Apr. 30, 2026
Apr. 30, 2025
Deferred tax assets:    
Net operating loss carryforwards $ 16,079,880 $ 15,026,112
Stock compensation 569,229 523,822
Research and development 63,232 216,831
Investment in SG Austria 439,953 439,953
Intangible asset (diabetes license) 559,672 559,672
Intangible asset (value of cells) 433,585 0
Fair value of investment in QCLS 511,464 0
Fair value of warrant asset 493,351 0
Other - deferred tax asset 217,244 147,798
Total deferred tax assets 19,367,610 16,914,188
Deferred tax liabilities:    
Fair value of convertible note receivable 0 (568,067)
Fair value of warrant asset 0 (228,906)
Fair value of investment in QCLS 0 (754,512)
Other - deferred tax liability 0 (140,985)
Total deferred tax liabilities (1,692,470)
Total deferred tax assets 19,367,610 15,221,718
Valuation allowance (19,367,610) (15,221,718)
Net deferred tax assets $ 0 $ 0